Novo Nordisk shares gain after competitor pulls out of China
Generic maker pulls out of China Market seen as too competitive Novo enters Indian market Diabetes and weight loss specialist Novo Nordisk (NOVO-B:CPH) skipped 2% higher after leading Indian generic drugs maker Biocon abandoned...
27 June 2025